{"gene":"NCF1","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":2001,"finding":"The PX domain of p47phox binds specifically to phosphatidylinositol-3,4-bisphosphate (PtdIns(3,4)P2); an Arg-to-Gln mutation in the PX domain found in chronic granulomatous disease patients eliminates this phosphoinositide binding.","method":"Lipid-binding assays, site-directed mutagenesis of PX domain","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro lipid binding assays combined with disease-linked mutagenesis; replicated conceptually across multiple phosphoinositide-binding studies","pmids":["11433300"],"is_preprint":false},{"year":1994,"finding":"During neutrophil activation, p47phox is phosphorylated on multiple C-terminal serine residues (Ser-303, Ser-304, Ser-320, Ser-328, Ser-345, Ser-348, and at least one of Ser-359/370/379); Ser-303, Ser-304, Ser-320, and Ser-328 are in PKC consensus sequences, while Ser-345 and Ser-348 are in MAPK (-PXSP-) consensus sequences.","method":"32Pi labeling of immunopurified p47phox from PMA-stimulated neutrophils, CNBr fragmentation, phosphopeptide mapping","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct phosphopeptide mapping in primary cells, replicated by multiple subsequent studies","pmids":["8089108"],"is_preprint":false},{"year":1996,"finding":"Both p38 MAPK and ERK1/2 phosphorylate p47phox at the same proline-directed site(s) in vitro; JNK does not phosphorylate p47phox.","method":"In vitro kinase assays with purified p38, ERK, and JNK using recombinant p47phox as substrate","journal":"Archives of biochemistry and biophysics","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro kinase assay with three kinases tested comparatively in a single study","pmids":["8900416"],"is_preprint":false},{"year":1996,"finding":"Using 2D tryptic phosphopeptide mapping with p47phox Ser→Ala mutants expressed in B lymphoblasts: PKC phosphorylates peptides containing Ser303/304, Ser315, Ser320, Ser328, and Ser359/370; PKA phosphorylates Ser320 and Ser328/359/370; MAPK phosphorylates only Ser345/348. These three kinases thus phosphorylate distinct subsets of serines.","method":"Two-dimensional tryptic phosphopeptide mapping, site-directed mutagenesis (Ser→Ala), in vitro kinase assays with PKC, PKA, and MAPK","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution with multiple mutants and multiple purified kinases, confirmed in intact cells","pmids":["8626435"],"is_preprint":false},{"year":2006,"finding":"GM-CSF and TNF-alpha prime NADPH oxidase activity by inducing phosphorylation of p47phox specifically at Ser345 via convergent MAPK pathways: ERK1/2 mediates GM-CSF-induced Ser345 phosphorylation, while p38 MAPK mediates TNF-alpha-induced Ser345 phosphorylation. A S345A mutant p47phox fails to support priming.","method":"Tandem mass spectrometry peptide sequencing, MAPK pathway inhibitors, S345A mutagenesis in HL-60 cells, cell-permeable TAT-peptide inhibition","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1 / Strong — mass spectrometry identification + mutagenesis + inhibitor studies + peptide competition, multiple orthogonal methods","pmids":["16778989"],"is_preprint":false},{"year":2000,"finding":"The ERK1/2 pathway participates in fMLP-induced p47phox phosphorylation in intact human neutrophils; ERK1/2 and PKC act additively on p47phox phosphorylation in fMLP-stimulated cells, identifying p47phox as a convergence point for these kinase cascades.","method":"ERK1/2 inhibitors (PD98059, U0126), PKC inhibitor (GF109203X), 2D phosphopeptide mapping in primary neutrophils","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — pharmacological inhibition with two orthogonal ERK inhibitors plus 2D phosphopeptide mapping in primary cells","pmids":["11046057"],"is_preprint":false},{"year":2001,"finding":"PKC-zeta phosphorylates p47phox at Ser303/304 and Ser315 in vitro; PKC-zeta inhibition blocks fMLP-induced p47phox phosphorylation and membrane translocation as well as superoxide production in human neutrophils.","method":"In vitro kinase assay with recombinant PKC-zeta and p47phox, site-directed mutagenesis, cell-permeable peptide antagonist, antisense oligonucleotides in HL-60 cells","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay with mutagenesis plus antisense knockdown and peptide inhibition in primary cells","pmids":["11145703"],"is_preprint":false},{"year":1999,"finding":"p47phox directly interacts with PKC-beta(I), PKC-beta(II), and PKC-delta via its C-terminus; co-immunoprecipitation confirmed this interaction in intact cells; p47phox acts as a regulator of PKC localization and substrate phosphorylation in neutrophils.","method":"p47phox affinity chromatography to extract kinase, co-immunoprecipitation, subcellular fractionation in p47phox-deficient cells, in vitro reconstitution with rat brain cytosol","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — affinity chromatography identification plus reciprocal co-IP plus functional reconstitution in p47phox-null cells","pmids":["10585874"],"is_preprint":false},{"year":2004,"finding":"PKC-delta is required for p47phox phosphorylation and membrane translocation in activated human monocytes; p47phox serves as a direct substrate for PKC-delta in vitro.","method":"Pharmacological inhibitors (rottlerin), PKC-delta antisense oligonucleotides, in vitro kinase assay with recombinant p47phox-GST fusion protein","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay plus genetic (antisense) and pharmacological inhibition in primary human monocytes","pmids":["15494525"],"is_preprint":false},{"year":1997,"finding":"PKC phosphorylation of p47phox induces a conformational change in the C-terminal region (detected by decreased reactivity of Cys378 to N-ethylmaleimide), revealing a binding site for interaction with cytochrome b558 during oxidase assembly.","method":"Chemical modification assay (N-ethylmaleimide reactivity) on PKC-phosphorylated vs. unphosphorylated p47phox, cell-free oxidase activation system","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct biochemical demonstration of phosphorylation-dependent conformational change with functional cell-free system validation","pmids":["9200696"],"is_preprint":false},{"year":1997,"finding":"Kinase-dependent phosphorylation of p47phox is required for NADPH oxidase activation in a cell-free system; PKC-phosphorylated p47phox, but not PKA- or MAPK-phosphorylated p47phox, supports oxidase activation; the S379A mutant is inactive in both whole cells and in this cell-free system.","method":"Two-stage cell-free oxidase activation assay, kinase-phosphorylated p47phox preparations, S379A mutant analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — cell-free reconstitution with site-specific mutants and defined phosphorylated substrates from three different kinases","pmids":["9110996"],"is_preprint":false},{"year":1993,"finding":"Translocation of p47phox (and p67phox) from cytosol to plasma membrane is an essential and continuous requirement for NADPH oxidase activation; phosphorylation of p47phox can be dissociated from translocation (staurosporine markedly inhibits phosphorylation but not translocation).","method":"Subcellular fractionation, immunoblotting of p47phox and p67phox in normal and Ca2+-depleted neutrophils with multiple agonists, staurosporine inhibition","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — systematic dissection of phosphorylation vs. translocation using multiple agonists and inhibitors in primary cells","pmids":["8439286"],"is_preprint":false},{"year":1995,"finding":"The C-terminal proline-rich region of p47phox interacts with the second SH3 domain of p67phox; p47phox also interacts with p40phox; these interactions are not required for oxidase activity in the cell-free assay.","method":"Protein overlay (far Western), deletion mutagenesis of p47phox and p67phox, solution binding studies, cell-free oxidase assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct binding assay with defined deletion mutants plus functional cell-free assay","pmids":["7744754"],"is_preprint":false},{"year":2005,"finding":"Crystal structure of the SH3 domain of p40phox (SH3p40) alone and in complex with a 12-residue proline-rich region of p47phox revealed that SH3p40 interacts with both a canonical polyproline motif and a non-canonical motif of the p47phox C-terminus. Phosphorylation of Ser-379 (but not Ser-359/370) destabilizes binding to both SH3p40 and C-SH3p67.","method":"X-ray crystallography (1.46 Å resolution), intrinsic tryptophan fluorescence binding measurements, phosphorylation-state analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus quantitative binding measurements with phosphopeptide variants","pmids":["15657040"],"is_preprint":false},{"year":2012,"finding":"The region of p47phox spanning residues 228-235 (specifically Thr233, and to a lesser degree Tyr231 and Val232) in the SH3 region is vital for NOX2 complex activation and for membrane translocation of p47phox upon stimulation.","method":"Site-directed mutagenesis of p47phox (deletion and single amino-acid substitutions), COS(PHOX) cell transfection, ROS assays, membrane translocation studies","journal":"Journal of leukocyte biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic mutagenesis of multiple residues with functional and localization readouts in a reconstituted cell system","pmids":["23271700"],"is_preprint":false},{"year":2003,"finding":"p47phox associates with the actin-binding protein cortactin and co-localizes with F-actin in Ang II-stimulated human VSMCs; disruption of the actin cytoskeleton prevents p47phox:actin interaction and attenuates ROS generation and p38MAPK/Akt signaling.","method":"Co-immunoprecipitation (p47phox with actin and cortactin), immunofluorescence confocal microscopy, cytochalasin disruption with functional readouts","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP plus live-cell imaging plus functional inhibition, replicated across multiple experimental conditions","pmids":["15618548"],"is_preprint":false},{"year":2003,"finding":"c-Src regulates Ang II-mediated NADPH oxidase activity by stimulating p47phox serine phosphorylation and translocation from cytosol to membrane; c-Src knockout cells show decreased p47phox phosphorylation and blunted Ang II-induced oxidase activation.","method":"Co-immunoprecipitation with anti-phosphoserine antibody, immunofluorescence, c-Src-/- mouse cells, c-Src inhibitor PP2","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout plus pharmacological inhibition in primary cells; single lab","pmids":["12663375"],"is_preprint":false},{"year":2004,"finding":"p47phox interacts with the tandem SH3 domains to bind the proline-rich region of p22phox, enabling NOX2 complex assembly; p47phox also activates Nox3 (in addition to gp91phox/NOX2), and deletion of the autoinhibitory region of p47phox renders it constitutively active toward both gp91phox and Nox3.","method":"Cell-based oxidase activation assays, autoinhibitory region deletion mutants, PMA stimulation experiments","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-based functional assays with multiple mutants; single lab","pmids":["15181005"],"is_preprint":false},{"year":2001,"finding":"Membrane-targeted PI3-kinase induces wortmannin-sensitive continuous phosphorylation of p47phox in monoblastic cells, placing PI3K upstream of p47phox phosphorylation.","method":"Transfection of membrane-targeted PI3K construct in GM-1 cells, wortmannin inhibition, immunoblotting for p47phox phosphorylation","journal":"Current biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic gain-of-function plus pharmacological inhibition; single lab","pmids":["8939574"],"is_preprint":false},{"year":2007,"finding":"PI3K/p110alpha (but not p110beta) mediates PDGF-AA-dependent membrane recruitment of p47phox and Rac-1, leading to NOX activation and ROS production; p47phox-null cells fail to generate PDGF-dependent ROS; ROS are required for PDGF-dependent chemotaxis but not proliferation.","method":"p47phox-/- cells, dominant-negative Rac-1, mutant alphaPDGFR lacking specific signaling sites, PI3K isoform-specific inhibition, subcellular fractionation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout plus multiple mutant receptors plus isoform-specific inhibition; multiple orthogonal approaches","pmids":["18070887"],"is_preprint":false},{"year":2019,"finding":"Cytosolic PCNA directly interacts with the PX domain of p47phox via its interdomain-connecting loop (demonstrated by surface plasmon resonance and crystallography), and this association regulates NADPH oxidase ROS production; PCNA inhibition decreases NADPH oxidase activation.","method":"Surface plasmon resonance, X-ray crystallography, competing peptides, PCNA inhibitor T2AA in vitro and in vivo (TNBS colitis model)","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus SPR binding plus functional inhibition in vitro and in vivo","pmids":["31492810"],"is_preprint":false},{"year":2003,"finding":"p47phox directly interacts with RelA (NF-kappaB subunit) via its tandem SH3 domains binding to a proline-rich mid-region of RelA; this interaction facilitates IL-1beta-induced RelA phosphorylation and transactivation without affecting IkappaB degradation or RelA nuclear translocation.","method":"Yeast two-hybrid, co-immunoprecipitation, in vitro binding, co-localization by immunofluorescence, RelA-PR peptide competition, luciferase reporter assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — yeast two-hybrid plus co-IP plus in vitro binding plus functional reporter assays with competing peptide; multiple orthogonal methods","pmids":["12618429"],"is_preprint":false},{"year":2017,"finding":"p47phox physically binds to Nrf2 (but not p65phox or p40phox), suppresses Nrf2 ubiquitination by Keap1 (while p47phox itself becomes ubiquitinated by Keap1), and promotes Nrf2 nuclear translocation and target gene expression.","method":"Co-immunoprecipitation, ubiquitination assays, p47phox genetic ablation, selective p47phox overexpression in mouse lungs","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus ubiquitination assay plus KO phenotype; single lab","pmids":["28939422"],"is_preprint":false},{"year":2011,"finding":"Ncf1/p47phox expression in Tregs is required for NADPH oxidase-derived ROS-mediated direct suppression of CD4+ effector T cells; Ncf1-deficient Tregs suppress Ncf1-deficient Teffs very poorly; NADPH oxidase inhibitors and antioxidants block WT Treg-mediated suppression.","method":"Treg/Teff co-culture suppression assays with Ncf1-/- mice, NADPH oxidase inhibitors (DPI, VAS-2870), antioxidants (NAC, 2-ME), flow cytometry of CFSE dilution","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout plus pharmacological inhibition in cell-based assays; single lab","pmids":["21253614"],"is_preprint":false},{"year":2001,"finding":"Fusion proteins linking truncated p47phox(1-286) N-terminally to truncated p67phox(1-210) reconstitute NADPH oxidase with 8-fold higher efficiency and greater stability than individual components, and show nearly full activation without anionic amphiphile, supporting a model of direct p47phox-p67phox-cytochrome b558 topology.","method":"Cell-free NADPH oxidase reconstitution with fusion protein constructs, superoxide production assays, Km determination for NADPH","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — cell-free reconstitution with systematically designed fusion proteins; single lab","pmids":["11333262"],"is_preprint":false},{"year":2004,"finding":"HBP1 transcriptional repressor directly binds six tandem HBP1 DNA-binding elements at positions -1243 to -1318 bp of the p47phox gene promoter, represses p47phox endogenous gene expression in a sequence-specific manner, and thereby reduces intracellular superoxide production to inhibit G1 cell cycle progression.","method":"Promoter-reporter assays, HBP1 dominant-negative mutant, electrophoretic mobility shift, chromatin immunoprecipitation (implied), intracellular superoxide measurement","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter binding demonstrated plus functional consequences of HBP1 expression/dominant-negative; single lab","pmids":["15024088"],"is_preprint":false},{"year":2019,"finding":"SRF recruits the histone acetyltransferase KAT8 to epigenetically activate NCF1/NCF2 transcription during hepatic stellate cell activation, thereby increasing ROS production and promoting liver fibrosis; SRF conditional knockout reduces NCF1/NCF2 expression and ROS in HSCs.","method":"HSC-conditional SRF knockout mice, chromatin immunoprecipitation, co-immunoprecipitation of SRF with KAT8, siRNA knockdown, ROS measurement","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO mouse plus ChIP plus co-IP showing SRF-KAT8 interaction at NCF1 promoter; single lab","pmids":["31442911"],"is_preprint":false},{"year":2009,"finding":"Aryl hydrocarbon receptor (AhR) directly binds a xenobiotic-responsive element (XRE) in the NCF1 promoter upon benzo(a)pyrene stimulation, inducing NCF1/p47phox transcription, protein translocation, and priming of macrophage superoxide production.","method":"AhR siRNA knockdown, chemical AhR inhibition, NCF1 promoter-luciferase assay, EMSA, chromatin immunoprecipitation, p47phox translocation and ROS assays","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus EMSA plus promoter-reporter assay plus functional ROS measurements; single lab","pmids":["19559082"],"is_preprint":false},{"year":2000,"finding":"p47phox is genetically required for superoxide production by microglial cells: p47phox-deficient microglia fail to produce superoxide, and retroviral transduction of human p47phox cDNA restores superoxide generation with normal kinetics.","method":"p47phox-/- knockout mice, primary microglial cultures, retroviral transduction with human p47phox cDNA, superoxide assays","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO plus rescue by cDNA complementation in primary cells","pmids":["11156938"],"is_preprint":false},{"year":2006,"finding":"The PX domain of p47phox translocates to the plasma membrane in activated human neutrophils but does not associate with the membrane of mature phagosomes (unlike RhoB).","method":"Nucleofection of primary human neutrophils with GFP-tagged p47phox PX domain constructs, live-cell fluorescence microscopy","journal":"BMC immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct live imaging in primary human cells with specific domain construct; single lab","pmids":["17150107"],"is_preprint":false},{"year":2011,"finding":"A single nucleotide polymorphism at position 153 of Ncf1 (M153T substitution, located in the hinge region between PX and SH3 domains) regulates ROS production and arthritis resistance; it does not affect p47phox/p67phox cytosolic complex assembly or membrane localization but likely affects downstream NOX2 complex activity at the membrane.","method":"COS(PHOX) cell transfection with mutated Ncf1 constructs, backcross genetics to DA strain, granulocyte ROS assays, p47phox/p67phox co-assembly and membrane localization assays","journal":"Antioxidants & redox signaling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional mutagenesis in cell system plus backcross genetics; single lab","pmids":["21275845"],"is_preprint":false},{"year":2022,"finding":"NCF1 p.R90H variant reduces p47phox affinity for phospholipids, impairing its endosomal localization; the resulting defect in NOX2-derived ROS at endosomes leads to acidified endosomal pH and facilitated TLR-dependent signaling in plasmacytoid dendritic cells, promoting lupus pathogenesis.","method":"Human NCF1 p.R90H knockin mice, pDC-conditional Cre knockout, phospholipid binding assays, endosomal pH measurement, TLR signaling assays, IFN-α measurement","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockin mice plus phospholipid binding assays plus mechanistic pathway analysis; single lab","pmids":["35788118"],"is_preprint":false},{"year":2023,"finding":"NCF1-dependent ROS production in plasmacytoid dendritic cells (pDCs) suppresses lupus by limiting pDC accumulation through inhibition of the AKT/mTOR pathway and CCR2-mediated tissue migration, and by dampening the STING/IFN-α/JAK1/STAT1 cascade.","method":"Cell-specific Cre-deleter knockout mice, NCF1-339 human variant knockin mice, transgenic reconstitution, AKT/mTOR pathway analysis, IFN-α and STING pathway measurements","journal":"JCI insight","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-type-specific genetic ablation with multiple mechanistic pathway readouts; single lab","pmids":["36853827"],"is_preprint":false},{"year":2024,"finding":"Macrophage NCF1 promotes Kupffer cell ferroptosis and MASH progression by oxidizing phospholipids; the oxidized phospholipids trigger TLR4-dependent hepcidin production in hepatocytes, leading to increased iron deposition and subsequent ferroptosis in Kupffer cells.","method":"Macrophage-specific NCF1 knockout mice, oxidized phospholipid measurements, TLR4 signaling assays, hepcidin measurement, iron deposition and ferroptosis assays","journal":"Cell metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-type-specific KO with mechanistic pathway dissection; single lab, multiple readouts","pmids":["38851189"],"is_preprint":false},{"year":2020,"finding":"p47phox translocates to the membrane in platelets after CRP or thrombin stimulation and interacts with both NOX1 and NOX2; p47phox deficiency impairs platelet ROS generation, aggregation, spreading, and clot retraction, and reduces phosphorylation of Syk and PLCγ2.","method":"p47phox-/- mice, platelet function assays, co-immunoprecipitation of p47phox with NOX1 and NOX2, phosphorylation analysis, in vivo thrombosis models","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO plus co-IP in stimulated platelets plus multiple functional assays; single lab","pmids":["32422541"],"is_preprint":false},{"year":2020,"finding":"Fragment-based drug discovery using fluorescence polarization and surface plasmon resonance identified small molecules binding to two distinct sites in the tandem SH3 domain of p47phox (p47phoxSH3A-B); a dimeric optimized compound inhibits the p47phoxSH3A-B–p22phox protein-protein interaction with Ki of 20 μM.","method":"Fragment screening by FP and thermal shift assay, SPR validation, structural studies, p22phox competition assay","journal":"Journal of medicinal chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — SPR binding plus structural characterization plus competition assay defining interaction sites; single lab","pmids":["31922756"],"is_preprint":false},{"year":2017,"finding":"PKCδ co-immunoprecipitates with p47phox in methamphetamine-treated mouse brain; PKCδ knockout or p47phox knockout each abolish methamphetamine-induced increases in NADPH oxidase activity and ROS, and rottlerin (PKCδ inhibitor) provides no additive protection over p47phox knockout, placing PKCδ upstream of p47phox in this pathway.","method":"Co-immunoprecipitation, PKCδ and p47phox knockout mice, PKCδ antisense oligonucleotides, NADPH oxidase activity and ROS assays","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus genetic double-KO epistasis; single lab","pmids":["29269308"],"is_preprint":false}],"current_model":"NCF1/p47phox is a cytosolic organizer subunit of the phagocyte NADPH oxidase (NOX2 complex) that, upon cell activation, undergoes PKC-, ERK1/2-, p38 MAPK-, and PKCδ/ζ-mediated multi-site serine phosphorylation (key sites: Ser303/304, Ser315, Ser320, Ser328, Ser345, Ser348, Ser379) triggering a conformational change that relieves autoinhibition and enables p47phox to translocate from cytosol to the plasma membrane via its PX domain (which binds PtdIns(3,4)P2) and its tandem SH3 domains (which bind the proline-rich region of p22phox), assembling the active oxidase complex with p67phox, p40phox, Rac, and flavocytochrome b558 to generate superoxide; p47phox also scaffolds PKC isoforms, interacts with the actin cytoskeleton through cortactin, directly binds RelA to facilitate NF-κB transactivation, and interacts with PCNA and Nrf2 to modulate oxidative stress responses, while functioning in NOX1 and Nox3 regulation as well."},"narrative":{"mechanistic_narrative":"NCF1/p47phox is the cytosolic organizer subunit of the phagocyte NADPH oxidase, providing the regulated assembly step that gates superoxide generation by the membrane flavocytochrome b558/NOX complex [PMID:8439286, PMID:11156938]. In resting cells p47phox is autoinhibited; cell activation triggers PKC-, ERK1/2-, and p38 MAPK-mediated phosphorylation of a cluster of C-terminal serines, with distinct kinases targeting distinct sites — PKC isoforms (including PKCζ at Ser303/304/315 and PKCδ) act on the PKC consensus serines while MAPKs act exclusively on the proline-directed Ser345/Ser348 [PMID:8089108, PMID:8626435, PMID:11145703, PMID:15494525]. This phosphorylation induces a conformational change in the C-terminus that exposes binding surfaces required for assembly [PMID:9200696], and only PKC-phosphorylated p47phox supports oxidase activation in cell-free reconstitution, with Ser379 essential for activity [PMID:9110996]. Once de-repressed, p47phox docks at the membrane through its PX domain, which binds PtdIns(3,4)P2 [PMID:11433300], and its tandem SH3 domains, which engage the proline-rich region of p22phox, nucleating complex assembly with p67phox and p40phox [PMID:7744754, PMID:15657040, PMID:15181005]. Phosphorylation at sites such as Ser345 underlies cytokine priming (GM-CSF via ERK1/2, TNF-α via p38) of the oxidase [PMID:16778989], and upstream PI3K signaling and c-Src feed into p47phox phosphorylation and recruitment in non-phagocytic cells [PMID:12663375, PMID:8939574, PMID:18070887]. Beyond the canonical oxidase, p47phox scaffolds PKC isoforms via its C-terminus [PMID:10585874], associates with the actin cytoskeleton through cortactin [PMID:15618548], directly binds RelA through its SH3 domains to facilitate NF-κB transactivation [PMID:12618429], and binds PCNA and Nrf2 to tune oxidative-stress responses [PMID:31492810, PMID:28939422]. Disease-relevant variants illustrate its physiology: a PX-domain Arg-to-Gln mutation abolishing phosphoinositide binding underlies chronic granulomatous disease [PMID:11433300], and the R90H variant impairing endosomal phospholipid binding promotes TLR-driven lupus pathogenesis [PMID:35788118]. p47phox-dependent ROS additionally regulate immune and tissue homeostasis, from Treg-mediated suppression of effector T cells [PMID:21253614] to platelet activation [PMID:32422541] and roles in fibrosis and MASH progression [PMID:31442911, PMID:38851189].","teleology":[{"year":1993,"claim":"Established that p47phox membrane translocation, not merely its phosphorylation, is the obligate continuous step for oxidase activation, separating two regulatory events that had been conflated.","evidence":"Subcellular fractionation and immunoblotting in normal and Ca2+-depleted neutrophils with staurosporine","pmids":["8439286"],"confidence":"High","gaps":["Did not define the membrane docking determinants","Mechanism coupling phosphorylation to translocation unresolved"]},{"year":1994,"claim":"Mapped the C-terminal multi-site serine phosphorylation of activated p47phox and assigned sites to PKC versus MAPK consensus motifs, defining the substrate landscape for oxidase regulation.","evidence":"32Pi labeling, CNBr fragmentation, and phosphopeptide mapping of p47phox from PMA-stimulated neutrophils","pmids":["8089108"],"confidence":"High","gaps":["Which kinases hit which sites in vivo not established","Functional consequence of individual sites untested here"]},{"year":1996,"claim":"Resolved that PKC, PKA, and MAPK phosphorylate distinct serine subsets, with MAPK restricted to the proline-directed Ser345/348, establishing p47phox as an integration node for multiple kinase cascades.","evidence":"2D tryptic phosphopeptide mapping of Ser→Ala mutants in B lymphoblasts and in vitro kinase assays; comparative in vitro assays with p38, ERK, JNK","pmids":["8626435","8900416"],"confidence":"High","gaps":["Did not test which sites drive activation versus priming","In-cell stoichiometry not quantified"]},{"year":1997,"claim":"Demonstrated that phosphorylation acts mechanistically by inducing a C-terminal conformational change and that only PKC-phosphorylated p47phox (with Ser379 intact) supports activation, providing the causal link between phosphorylation and assembly.","evidence":"N-ethylmaleimide reactivity assay and two-stage cell-free oxidase reconstitution with kinase-specific phosphorylated p47phox and S379A mutant","pmids":["9200696","9110996"],"confidence":"High","gaps":["Atomic structure of the conformational change not resolved","Why PKA/MAPK phosphorylation is insufficient alone unexplained"]},{"year":1995,"claim":"Identified the SH3-mediated and proline-rich interactions linking p47phox to p67phox and p40phox, beginning the structural map of complex assembly.","evidence":"Far-Western overlay, deletion mutagenesis, and solution binding with cell-free oxidase assay","pmids":["7744754"],"confidence":"High","gaps":["These interactions found dispensable in cell-free assay, leaving their in-cell role open","Did not define p22phox docking"]},{"year":2001,"claim":"Defined the PX domain as a PtdIns(3,4)P2-binding membrane-targeting module and tied a CGD patient mutation to loss of this binding, explaining how p47phox is recruited to membranes.","evidence":"Lipid-binding assays with PX-domain site-directed and disease-linked mutagenesis","pmids":["11433300"],"confidence":"High","gaps":["Did not address SH3-mediated p22phox docking","In vivo lipid specificity in different cell types not tested"]},{"year":2001,"claim":"Placed PKCζ and membrane-targeted PI3K upstream of p47phox phosphorylation and translocation, extending the activating kinase network beyond conventional PKC.","evidence":"In vitro kinase assays with recombinant PKCζ, antisense/peptide inhibition in HL-60 cells; membrane-targeted PI3K transfection with wortmannin","pmids":["11145703","8939574"],"confidence":"High","gaps":["PKCζ vs conventional PKC site selectivity in vivo unresolved","PI3K-to-kinase connection indirect"]},{"year":2004,"claim":"Showed p47phox also activates Nox3 and binds the p22phox proline-rich region via tandem SH3 domains, and that PKCδ drives its phosphorylation/translocation in monocytes, broadening its NOX-organizing role.","evidence":"Cell-based oxidase assays with autoinhibitory deletion mutants; PKCδ antisense, rottlerin, and in vitro kinase assays in monocytes","pmids":["15181005","15494525"],"confidence":"Medium","gaps":["NOX-isoform selectivity determinants not mapped","Single-lab cell-based data"]},{"year":2005,"claim":"Provided atomic detail of p40phox SH3 binding to canonical and non-canonical motifs of the p47phox C-terminus and showed Ser379 phosphorylation destabilizes these interactions, linking phosphorylation to release of intramolecular/intermolecular contacts.","evidence":"1.46 Å crystal structure of SH3p40–p47phox peptide complex with tryptophan-fluorescence binding measurements","pmids":["15657040"],"confidence":"High","gaps":["Full-length autoinhibited structure not solved","Dynamics of the phosphorylation switch not captured"]},{"year":2006,"claim":"Established Ser345 as the molecular basis of cytokine priming, with GM-CSF/ERK1/2 and TNF-α/p38 converging on this single residue, explaining how inflammatory signals amplify oxidase output.","evidence":"Tandem MS, MAPK inhibitors, S345A mutagenesis in HL-60, and TAT-peptide inhibition","pmids":["16778989"],"confidence":"High","gaps":["How Ser345 phosphorylation primes without full activation not detailed","Proline isomerase involvement not addressed"]},{"year":2000,"claim":"Demonstrated genetic requirement for p47phox in oxidase function via knockout and cDNA rescue, formally establishing it as essential and non-redundant for superoxide production.","evidence":"p47phox-/- microglia with retroviral human p47phox cDNA complementation and superoxide assays","pmids":["11156938"],"confidence":"High","gaps":["Did not address tissue-specific roles","ERK pathway contribution to fMLP response left to other work"]},{"year":2003,"claim":"Revealed moonlighting roles of p47phox beyond superoxide production: scaffolding cortactin/actin and directly binding RelA to facilitate NF-κB transactivation, connecting the oxidase organizer to cytoskeleton and transcription.","evidence":"Reciprocal co-IP and imaging in VSMCs; yeast two-hybrid, co-IP, in vitro binding, and reporter assays for RelA; c-Src KO/inhibitor studies","pmids":["15618548","12618429","12663375"],"confidence":"Medium","gaps":["Whether scaffolding functions require oxidase activity unclear","RelA interaction effects on specific target genes incompletely mapped"]},{"year":2012,"claim":"Identified an SH3-region segment (Thr233/Tyr231/Val232) and an M153T hinge polymorphism as determinants of membrane translocation and ROS output, refining the structural map of activation control.","evidence":"Systematic mutagenesis in COS(PHOX) cells with ROS and translocation readouts; backcross genetics linking M153T to arthritis resistance","pmids":["23271700","21275845"],"confidence":"Medium","gaps":["Mechanism by which M153T alters membrane-stage activity unresolved","Single reconstituted cell system"]},{"year":2017,"claim":"Extended p47phox into redox-homeostasis and stress signaling by showing it binds Nrf2 to block Keap1-mediated ubiquitination and scaffolds PKCδ in neurotoxicity, positioning it as a regulator of antioxidant transcription and PKC localization.","evidence":"Co-IP, ubiquitination assays, and p47phox genetic ablation for Nrf2; co-IP and PKCδ/p47phox double-KO epistasis in methamphetamine-treated brain","pmids":["28939422","29269308"],"confidence":"Medium","gaps":["Direct Nrf2 binding interface not defined","Single-lab studies"]},{"year":2019,"claim":"Discovered direct PCNA binding to the p47phox PX domain and transcriptional control of NCF1 by SRF/KAT8, adding cytosolic-cofactor and epigenetic layers to oxidase regulation.","evidence":"SPR and crystallography with PCNA inhibitor in colitis model; conditional SRF-KO mice with ChIP and SRF-KAT8 co-IP","pmids":["31492810","31442911"],"confidence":"Medium","gaps":["How PCNA binding integrates with phosphorylation switch unclear","SRF/KAT8 mechanism shown in single tissue context"]},{"year":2022,"claim":"Linked NCF1 sequence variants to autoimmune and metabolic disease mechanisms: R90H impairs endosomal phospholipid binding to promote TLR-driven lupus, while NCF1-derived ROS otherwise restrain pDC accumulation and IFN-α signaling.","evidence":"Human variant knockin and pDC-conditional KO mice with phospholipid binding, endosomal pH, and TLR/STING/IFN-α readouts","pmids":["35788118","36853827"],"confidence":"Medium","gaps":["Cell-type-specific contributions of endosomal vs plasma-membrane ROS not fully separated","Single-lab disease models"]},{"year":2024,"claim":"Defined a pathogenic axis in which macrophage NCF1 oxidizes phospholipids to drive TLR4/hepcidin-dependent iron-mediated Kupffer cell ferroptosis in MASH, illustrating tissue-level consequences of NCF1-dependent ROS.","evidence":"Macrophage-specific NCF1-KO mice with oxidized phospholipid, TLR4, hepcidin, and ferroptosis assays; platelet p47phox-/- studies of NOX1/NOX2 interaction","pmids":["38851189","32422541"],"confidence":"Medium","gaps":["Whether oxidized-phospholipid signaling is direct or via secondary mediators unclear","Single-lab models"]},{"year":null,"claim":"How the multi-site phosphorylation code, PX/SH3 lipid and protein docking, and cytosolic cofactors (PCNA, PKC isoforms) are integrated into a unified quantitative activation switch in full-length p47phox remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No full-length structure of the autoinhibited or assembled complex","Site-by-site contribution to activation vs priming not quantitatively reconciled","NOX-isoform-selective regulation determinants undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[12,13,17,21]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[0,29,31]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[7,17,22]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[15]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[11,7]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[11,0,29]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[31]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[15]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[28,23,31,32]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[4,22,20]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[21,16,19]}],"complexes":["NADPH oxidase (NOX2) complex"],"partners":["CYBA","NCF2","NCF4","RELA","PCNA","NFE2L2","CTTN","PRKCD"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P14598","full_name":"Neutrophil cytosol factor 1","aliases":["47 kDa autosomal chronic granulomatous disease protein","47 kDa neutrophil oxidase factor","NCF-47K","Neutrophil NADPH oxidase factor 1","Nox organizer 2","Nox-organizing protein 2","SH3 and PX domain-containing protein 1A","p47-phox"],"length_aa":390,"mass_kda":44.7,"function":"Subunit of the phagocyte NADPH oxidase complex that mediates the transfer of electrons from cytosolic NADPH to O2 to produce the superoxide anion (O2(-)) (PubMed:2547247, PubMed:2550933, PubMed:38355798). In the activated complex, electrons are first transferred from NADPH to flavin adenine dinucleotide (FAD) and subsequently transferred via two heme molecules to molecular oxygen, producing superoxide through an outer-sphere reaction (PubMed:38355798). Activation of the NADPH oxidase complex is initiated by the assembly of cytosolic subunits of the NADPH oxidase complex with the core NADPH oxidase complex to form a complex at the plasma membrane or phagosomal membrane (PubMed:38355798). This activation process is initiated by phosphorylation dependent binding of the cytosolic NCF1/p47-phox subunit to the C-terminus of CYBA/p22-phox (PubMed:12732142, PubMed:19801500)","subcellular_location":"Cytoplasm, cytosol; Membrane","url":"https://www.uniprot.org/uniprotkb/P14598/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NCF1","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1090,"dependency_fraction":0.0027522935779816515},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NCF1","total_profiled":1310},"omim":[{"mim_id":"614780","title":"SORTING NEXIN 10; SNX10","url":"https://www.omim.org/entry/614780"},{"mim_id":"611256","title":"NADPH OXIDASE ORGANIZER 1; NOXO1","url":"https://www.omim.org/entry/611256"},{"mim_id":"611255","title":"NADPH OXIDASE ACTIVATOR 1; NOXA1","url":"https://www.omim.org/entry/611255"},{"mim_id":"608515","title":"NEUTROPHIL CYTOSOLIC FACTOR 2; NCF2","url":"https://www.omim.org/entry/608515"},{"mim_id":"608512","title":"NEUTROPHIL CYTOSOLIC FACTOR 1; NCF1","url":"https://www.omim.org/entry/608512"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":84.4},{"tissue":"lymphoid tissue","ntpm":97.8}],"url":"https://www.proteinatlas.org/search/NCF1"},"hgnc":{"alias_symbol":["p47phox","NOXO2","NCF1A","SH3PXD1A"],"prev_symbol":[]},"alphafold":{"accession":"P14598","domains":[{"cath_id":"3.30.1520.10","chopping":"7-127_135-141","consensus_level":"high","plddt":88.9363,"start":7,"end":141},{"cath_id":"2.30.30.40","chopping":"165-213","consensus_level":"medium","plddt":90.6449,"start":165,"end":213},{"cath_id":"2.30.30.40","chopping":"230-305","consensus_level":"medium","plddt":94.2217,"start":230,"end":305}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P14598","model_url":"https://alphafold.ebi.ac.uk/files/AF-P14598-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P14598-F1-predicted_aligned_error_v6.png","plddt_mean":82.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NCF1","jax_strain_url":"https://www.jax.org/strain/search?query=NCF1"},"sequence":{"accession":"P14598","fasta_url":"https://rest.uniprot.org/uniprotkb/P14598.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P14598/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P14598"}},"corpus_meta":[{"pmid":"11433300","id":"PMC_11433300","title":"The PX domains of p47phox and p40phox bind to lipid products of PI(3)K.","date":"2001","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11433300","citation_count":525,"is_preprint":false},{"pmid":"19372727","id":"PMC_19372727","title":"p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases.","date":"2009","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19372727","citation_count":349,"is_preprint":false},{"pmid":"12716910","id":"PMC_12716910","title":"Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12716910","citation_count":316,"is_preprint":false},{"pmid":"12461526","id":"PMC_12461526","title":"Positional identification of Ncf1 as a gene that regulates arthritis severity in rats.","date":"2002","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12461526","citation_count":296,"is_preprint":false},{"pmid":"15310853","id":"PMC_15310853","title":"Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15310853","citation_count":291,"is_preprint":false},{"pmid":"8089108","id":"PMC_8089108","title":"The phosphorylation of the respiratory burst oxidase component p47phox during neutrophil activation. Phosphorylation of sites recognized by protein kinase C and by proline-directed kinases.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8089108","citation_count":277,"is_preprint":false},{"pmid":"18536919","id":"PMC_18536919","title":"Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane.","date":"2008","source":"Seminars in immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/18536919","citation_count":274,"is_preprint":false},{"pmid":"16778989","id":"PMC_16778989","title":"A specific p47phox -serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites.","date":"2006","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/16778989","citation_count":255,"is_preprint":false},{"pmid":"12663375","id":"PMC_12663375","title":"c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells.","date":"2003","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12663375","citation_count":228,"is_preprint":false},{"pmid":"8900416","id":"PMC_8900416","title":"Activation of p38 in stimulated human neutrophils: phosphorylation of the oxidase component p47phox by p38 and ERK but not by JNK.","date":"1996","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/8900416","citation_count":206,"is_preprint":false},{"pmid":"8626435","id":"PMC_8626435","title":"Phosphorylation of the respiratory burst oxidase subunit p47phox as determined by two-dimensional phosphopeptide mapping. Phosphorylation by protein kinase C, protein kinase A, and a mitogen-activated protein kinase.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8626435","citation_count":198,"is_preprint":false},{"pmid":"11145703","id":"PMC_11145703","title":"Protein kinase C zeta phosphorylates a subset of selective sites of the NADPH oxidase component p47phox and participates in formyl peptide-mediated neutrophil respiratory burst.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11145703","citation_count":187,"is_preprint":false},{"pmid":"14514646","id":"PMC_14514646","title":"Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy.","date":"2003","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/14514646","citation_count":182,"is_preprint":false},{"pmid":"16864727","id":"PMC_16864727","title":"Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.","date":"2006","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/16864727","citation_count":176,"is_preprint":false},{"pmid":"11046057","id":"PMC_11046057","title":"The mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway is involved in formyl-methionyl-leucyl-phenylalanine-induced p47phox phosphorylation in human neutrophils.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11046057","citation_count":161,"is_preprint":false},{"pmid":"15494525","id":"PMC_15494525","title":"Protein kinase C delta is required for p47phox phosphorylation and translocation in activated human monocytes.","date":"2004","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15494525","citation_count":151,"is_preprint":false},{"pmid":"19028840","id":"PMC_19028840","title":"Regulation of the phagocyte NADPH oxidase activity: phosphorylation of gp91phox/NOX2 by protein kinase C enhances its diaphorase activity and binding to Rac2, p67phox, and p47phox.","date":"2008","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/19028840","citation_count":139,"is_preprint":false},{"pmid":"15618548","id":"PMC_15618548","title":"p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II.","date":"2004","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15618548","citation_count":134,"is_preprint":false},{"pmid":"15181005","id":"PMC_15181005","title":"Nox3 regulation by NOXO1, p47phox, and p67phox.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15181005","citation_count":129,"is_preprint":false},{"pmid":"18028450","id":"PMC_18028450","title":"ASK1-p38 MAPK-p47phox activation is essential for inflammatory responses during tuberculosis via TLR2-ROS signalling.","date":"2007","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/18028450","citation_count":120,"is_preprint":false},{"pmid":"8939574","id":"PMC_8939574","title":"Constitutive activation of protein kinase B and phosphorylation of p47phox by a membrane-targeted phosphoinositide 3-kinase.","date":"1996","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/8939574","citation_count":117,"is_preprint":false},{"pmid":"28606963","id":"PMC_28606963","title":"A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus.","date":"2017","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/28606963","citation_count":115,"is_preprint":false},{"pmid":"22549734","id":"PMC_22549734","title":"The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes.","date":"2012","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/22549734","citation_count":114,"is_preprint":false},{"pmid":"18566433","id":"PMC_18566433","title":"Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18566433","citation_count":112,"is_preprint":false},{"pmid":"8439286","id":"PMC_8439286","title":"Relationship between phosphorylation and translocation to the plasma membrane of p47phox and p67phox and activation of the NADPH oxidase in normal and Ca(2+)-depleted human neutrophils.","date":"1993","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/8439286","citation_count":111,"is_preprint":false},{"pmid":"15670768","id":"PMC_15670768","title":"Angiotensin II induces MMP-2 in a p47phox-dependent manner.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15670768","citation_count":104,"is_preprint":false},{"pmid":"9116268","id":"PMC_9116268","title":"Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease.","date":"1997","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9116268","citation_count":100,"is_preprint":false},{"pmid":"27310928","id":"PMC_27310928","title":"Inhibition of autophagosome-lysosome fusion by ginsenoside Ro via the ESR2-NCF1-ROS pathway sensitizes esophageal cancer cells to 5-fluorouracil-induced cell death via the CHEK1-mediated DNA damage checkpoint.","date":"2016","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/27310928","citation_count":92,"is_preprint":false},{"pmid":"23755271","id":"PMC_23755271","title":"Zinc oxide nanoparticles induce necrosis and apoptosis in macrophages in a p47phox- and Nrf2-independent manner.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23755271","citation_count":91,"is_preprint":false},{"pmid":"21253614","id":"PMC_21253614","title":"Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cells.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21253614","citation_count":90,"is_preprint":false},{"pmid":"14993144","id":"PMC_14993144","title":"Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2- production, vascular tone, and mitogen-activated protein kinase activation.","date":"2004","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/14993144","citation_count":84,"is_preprint":false},{"pmid":"16626305","id":"PMC_16626305","title":"Homocysteine stimulates phosphorylation of NADPH oxidase p47phox and p67phox subunits in monocytes via protein kinase Cbeta activation.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16626305","citation_count":81,"is_preprint":false},{"pmid":"16532385","id":"PMC_16532385","title":"Hemizygosity at the NCF1 gene in patients with Williams-Beuren syndrome decreases their risk of hypertension.","date":"2006","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16532385","citation_count":78,"is_preprint":false},{"pmid":"14507659","id":"PMC_14507659","title":"Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models.","date":"2003","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/14507659","citation_count":78,"is_preprint":false},{"pmid":"18070887","id":"PMC_18070887","title":"Phosphatidylinositol 3-kinase-dependent membrane recruitment of Rac-1 and p47phox is critical for alpha-platelet-derived growth factor receptor-induced production of reactive oxygen species.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18070887","citation_count":76,"is_preprint":false},{"pmid":"9110996","id":"PMC_9110996","title":"Kinase-dependent activation of the leukocyte NADPH oxidase in a cell-free system. Phosphorylation of membranes and p47(PHOX) during oxidase activation.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9110996","citation_count":74,"is_preprint":false},{"pmid":"21728841","id":"PMC_21728841","title":"Copy number variation of the gene NCF1 is associated with rheumatoid arthritis.","date":"2011","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21728841","citation_count":71,"is_preprint":false},{"pmid":"10585874","id":"PMC_10585874","title":"Direct interaction between p47phox and protein kinase C: evidence for targeting of protein kinase C by p47phox in neutrophils.","date":"1999","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/10585874","citation_count":69,"is_preprint":false},{"pmid":"17157199","id":"PMC_17157199","title":"Ascorbate inhibits NADPH oxidase subunit p47phox expression in microvascular endothelial cells.","date":"2006","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17157199","citation_count":69,"is_preprint":false},{"pmid":"7744754","id":"PMC_7744754","title":"Interactions between the cytosolic components p47phox and p67phox of the human neutrophil NADPH oxidase that are not required for activation in the cell-free system.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7744754","citation_count":67,"is_preprint":false},{"pmid":"14504257","id":"PMC_14504257","title":"L-arginine reverses p47phox and gp91phox expression induced by high salt in Dahl rats.","date":"2003","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/14504257","citation_count":66,"is_preprint":false},{"pmid":"23085266","id":"PMC_23085266","title":"Zymosan induces NADPH oxidase activation in human neutrophils by inducing the phosphorylation of p47phox and the activation of Rac2: involvement of protein tyrosine kinases, PI3Kinase, PKC, ERK1/2 and p38MAPkinase.","date":"2012","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23085266","citation_count":66,"is_preprint":false},{"pmid":"31442911","id":"PMC_31442911","title":"Serum response factor (SRF) promotes ROS generation and hepatic stellate cell activation by epigenetically stimulating NCF1/2 transcription.","date":"2019","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/31442911","citation_count":64,"is_preprint":false},{"pmid":"18036262","id":"PMC_18036262","title":"Reactive oxygen species and p47phox activation are essential for the Mycobacterium tuberculosis-induced pro-inflammatory response in murine microglia.","date":"2007","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/18036262","citation_count":64,"is_preprint":false},{"pmid":"12241540","id":"PMC_12241540","title":"Glutamine plays a role in superoxide production and the expression of p47phox, p22phox and gp91phox in rat neutrophils.","date":"2002","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/12241540","citation_count":64,"is_preprint":false},{"pmid":"15657040","id":"PMC_15657040","title":"Effects of p47phox C terminus phosphorylations on binding interactions with p40phox and p67phox. Structural and functional comparison of p40phox and p67phox SH3 domains.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15657040","citation_count":64,"is_preprint":false},{"pmid":"36163178","id":"PMC_36163178","title":"A dual Keap1 and p47phox inhibitor Ginsenoside Rb1 ameliorates high glucose/ox-LDL-induced endothelial cell injury and atherosclerosis.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/36163178","citation_count":63,"is_preprint":false},{"pmid":"15024088","id":"PMC_15024088","title":"HBP1 repression of the p47phox gene: cell cycle regulation via the NADPH oxidase.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15024088","citation_count":63,"is_preprint":false},{"pmid":"9200696","id":"PMC_9200696","title":"Activation of the leukocyte NADPH oxidase subunit p47phox by protein kinase C. A phosphorylation-dependent change in the conformation of the C-terminal end of p47phox.","date":"1997","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9200696","citation_count":62,"is_preprint":false},{"pmid":"26133972","id":"PMC_26133972","title":"Ellagic Acid Prevents L-NAME-Induced Hypertension via Restoration of eNOS and p47phox Expression in Rats.","date":"2015","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/26133972","citation_count":60,"is_preprint":false},{"pmid":"15804439","id":"PMC_15804439","title":"Immunohistochemical study of p47Phox and gp91Phox distributions in rat brain.","date":"2005","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/15804439","citation_count":60,"is_preprint":false},{"pmid":"38851189","id":"PMC_38851189","title":"Reactive oxygen species regulation by NCF1 governs ferroptosis susceptibility of Kupffer cells to MASH.","date":"2024","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/38851189","citation_count":58,"is_preprint":false},{"pmid":"24126171","id":"PMC_24126171","title":"Williams syndrome predisposes to vascular stiffness modified by antihypertensive use and copy number changes in NCF1.","date":"2013","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/24126171","citation_count":56,"is_preprint":false},{"pmid":"18453614","id":"PMC_18453614","title":"Heme oxygenase-1 protects against neutrophil-mediated intestinal damage by down-regulation of neutrophil p47phox and p67phox activity and O2- production in a two-hit model of alcohol intoxication and burn injury.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18453614","citation_count":56,"is_preprint":false},{"pmid":"22798525","id":"PMC_22798525","title":"Phosphorylation of smooth muscle 22α facilitates angiotensin II-induced ROS production via activation of the PKCδ-P47phox axis through release of PKCδ and actin dynamics and is associated with hypertrophy and hyperplasia of vascular smooth muscle cells in vitro and in vivo.","date":"2012","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/22798525","citation_count":55,"is_preprint":false},{"pmid":"23271700","id":"PMC_23271700","title":"Identification of a region in p47phox/NCF1 crucial for phagocytic NADPH oxidase (NOX2) activation.","date":"2012","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/23271700","citation_count":54,"is_preprint":false},{"pmid":"23975181","id":"PMC_23975181","title":"Increased reactive oxygen species production and p47phox phosphorylation in neutrophils from myeloproliferative disorders patients with JAK2 (V617F) mutation.","date":"2013","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/23975181","citation_count":54,"is_preprint":false},{"pmid":"16972229","id":"PMC_16972229","title":"Chronic granulomatous disease caused by mutations other than the common GT deletion in NCF1, the gene encoding the p47phox component of the phagocyte NADPH oxidase.","date":"2006","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/16972229","citation_count":48,"is_preprint":false},{"pmid":"25565313","id":"PMC_25565313","title":"p47(phox) contributes to albuminuria and kidney fibrosis in mice.","date":"2015","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/25565313","citation_count":47,"is_preprint":false},{"pmid":"11156938","id":"PMC_11156938","title":"Genetic requirement of p47phox for superoxide production by murine microglia.","date":"2000","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/11156938","citation_count":46,"is_preprint":false},{"pmid":"1332032","id":"PMC_1332032","title":"O2- production by B lymphocytes lacking the respiratory burst oxidase subunit p47phox after transfection with an expression vector containing a p47phox cDNA.","date":"1992","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1332032","citation_count":44,"is_preprint":false},{"pmid":"26940604","id":"PMC_26940604","title":"Protective effect of resveratrol against chronic intermittent hypoxia-induced spatial memory deficits, hippocampal oxidative DNA damage and increased p47Phox NADPH oxidase expression in young rats.","date":"2016","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/26940604","citation_count":44,"is_preprint":false},{"pmid":"31704719","id":"PMC_31704719","title":"NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus.","date":"2019","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/31704719","citation_count":43,"is_preprint":false},{"pmid":"22653270","id":"PMC_22653270","title":"Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse.","date":"2012","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/22653270","citation_count":43,"is_preprint":false},{"pmid":"16920193","id":"PMC_16920193","title":"Translocation of proteins homologous to human neutrophil p47phox and p67phox to the cell membrane in activated hemocytes of Galleria mellonella.","date":"2006","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16920193","citation_count":41,"is_preprint":false},{"pmid":"29269308","id":"PMC_29269308","title":"PKCδ-dependent p47phox activation mediates methamphetamine-induced dopaminergic neurotoxicity.","date":"2017","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29269308","citation_count":40,"is_preprint":false},{"pmid":"21068125","id":"PMC_21068125","title":"Homocysteine enhances cell proliferation in vascular smooth muscle cells: role of p38 MAPK and p47phox.","date":"2010","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/21068125","citation_count":40,"is_preprint":false},{"pmid":"16275890","id":"PMC_16275890","title":"Impaired NADPH oxidase activity in Rac2-deficient murine neutrophils does not result from defective translocation of p47phox and p67phox and can be rescued by exogenous arachidonic acid.","date":"2005","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/16275890","citation_count":40,"is_preprint":false},{"pmid":"15936744","id":"PMC_15936744","title":"Ncf1 (p47phox) polymorphism determines oxidative burst and the severity of arthritis in rats and mice.","date":"2005","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15936744","citation_count":39,"is_preprint":false},{"pmid":"27343196","id":"PMC_27343196","title":"Hyperoxia-induced p47phox activation and ROS generation is mediated through S1P transporter Spns2, and S1P/S1P1&2 signaling axis in lung endothelium.","date":"2016","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27343196","citation_count":39,"is_preprint":false},{"pmid":"11333262","id":"PMC_11333262","title":"Fused p47phox and p67phox truncations efficiently reconstitute NADPH oxidase with higher activity and stability than the individual components.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11333262","citation_count":39,"is_preprint":false},{"pmid":"12546136","id":"PMC_12546136","title":"NADPH oxidase priming and p47phox phosphorylation in neutrophils from synovial fluid of patients with rheumatoid arthritis and spondylarthropathy.","date":"2002","source":"Inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/12546136","citation_count":39,"is_preprint":false},{"pmid":"16006535","id":"PMC_16006535","title":"Leukotriene B4 mediates p47phox phosphorylation and membrane translocation in polyunsaturated fatty acid-stimulated neutrophils.","date":"2005","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/16006535","citation_count":37,"is_preprint":false},{"pmid":"29195137","id":"PMC_29195137","title":"The NADPH organizers NoxO1 and p47phox are both mediators of diabetes-induced vascular dysfunction in mice.","date":"2017","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/29195137","citation_count":35,"is_preprint":false},{"pmid":"26209274","id":"PMC_26209274","title":"NAD(P)H oxidase subunit p47phox is elevated, and p47phox knockout prevents diaphragm contractile dysfunction in heart failure.","date":"2015","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/26209274","citation_count":35,"is_preprint":false},{"pmid":"7797495","id":"PMC_7797495","title":"The fatty acid bimodal action on superoxide anion production by human adherent monocytes under phorbol 12-myristate 13-acetate or diacylglycerol activation can be explained by the modulation of protein kinase C and p47phox translocation.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7797495","citation_count":35,"is_preprint":false},{"pmid":"25474113","id":"PMC_25474113","title":"P47phox-/- mice are compromised in expansion and activation of CD8+ T cells and susceptible to Trypanosoma cruzi infection.","date":"2014","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/25474113","citation_count":34,"is_preprint":false},{"pmid":"11166463","id":"PMC_11166463","title":"Mutational analysis of patients with p47-phox-deficient chronic granulomatous disease: The significance of recombination events between the p47-phox gene (NCF1) and its highly homologous pseudogenes.","date":"2001","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/11166463","citation_count":32,"is_preprint":false},{"pmid":"28919853","id":"PMC_28919853","title":"p47Phox/CDK5/DRP1-Mediated Mitochondrial Fission Evokes PV Cell Degeneration in the Rat Dentate Gyrus Following Status Epilepticus.","date":"2017","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28919853","citation_count":32,"is_preprint":false},{"pmid":"29695496","id":"PMC_29695496","title":"oxLDL-mediated cellular senescence is associated with increased NADPH oxidase p47phox recruitment to caveolae.","date":"2018","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/29695496","citation_count":32,"is_preprint":false},{"pmid":"36853827","id":"PMC_36853827","title":"NCF1-dependent production of ROS protects against lupus by regulating plasmacytoid dendritic cell development and functions.","date":"2023","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/36853827","citation_count":31,"is_preprint":false},{"pmid":"31492810","id":"PMC_31492810","title":"Cytosolic PCNA interacts with p47phox and controls NADPH oxidase NOX2 activation in neutrophils.","date":"2019","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31492810","citation_count":31,"is_preprint":false},{"pmid":"31922756","id":"PMC_31922756","title":"Developing Inhibitors of the p47phox-p22phox Protein-Protein Interaction by Fragment-Based Drug Discovery.","date":"2020","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31922756","citation_count":30,"is_preprint":false},{"pmid":"35788118","id":"PMC_35788118","title":"The NCF1 variant p.R90H aggravates autoimmunity by facilitating the activation of plasmacytoid dendritic cells.","date":"2022","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/35788118","citation_count":30,"is_preprint":false},{"pmid":"20920494","id":"PMC_20920494","title":"Lipopolysaccharide-induced cytokine expression in alveolar epithelial cells: role of PKCζ-mediated p47phox phosphorylation.","date":"2010","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/20920494","citation_count":30,"is_preprint":false},{"pmid":"11827466","id":"PMC_11827466","title":"Genomic organization of the genes Gtf2ird1, Gtf2i, and Ncf1 at the mouse chromosome 5 region syntenic to the human chromosome 7q11.23 Williams syndrome critical region.","date":"2002","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/11827466","citation_count":29,"is_preprint":false},{"pmid":"21275845","id":"PMC_21275845","title":"Positioning of a polymorphic quantitative trait nucleotide in the Ncf1 gene controlling oxidative burst response and arthritis severity in rats.","date":"2011","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21275845","citation_count":29,"is_preprint":false},{"pmid":"22222227","id":"PMC_22222227","title":"p47(phox) directs murine macrophage cell fate decisions.","date":"2012","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22222227","citation_count":29,"is_preprint":false},{"pmid":"15814300","id":"PMC_15814300","title":"Expression of NOX-I, gp91phox, p47phox and P67phox in the aorta segments above and below coarctation.","date":"2005","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/15814300","citation_count":28,"is_preprint":false},{"pmid":"17150107","id":"PMC_17150107","title":"Gene transfer and expression in human neutrophils. The phox homology domain of p47phox translocates to the plasma membrane but not to the membrane of mature phagosomes.","date":"2006","source":"BMC immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17150107","citation_count":28,"is_preprint":false},{"pmid":"23688784","id":"PMC_23688784","title":"Different unequal cross-over events between NCF1 and its pseudogenes in autosomal p47(phox)-deficient chronic granulomatous disease.","date":"2013","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/23688784","citation_count":27,"is_preprint":false},{"pmid":"24873968","id":"PMC_24873968","title":"Deficient production of reactive oxygen species leads to severe chronic DSS-induced colitis in Ncf1/p47phox-mutant mice.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24873968","citation_count":27,"is_preprint":false},{"pmid":"19559082","id":"PMC_19559082","title":"Aryl hydrocarbon receptor-dependent induction of the NADPH oxidase subunit NCF1/p47 phox expression leading to priming of human macrophage oxidative burst.","date":"2009","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19559082","citation_count":27,"is_preprint":false},{"pmid":"28939422","id":"PMC_28939422","title":"Suppressed ubiquitination of Nrf2 by p47phox contributes to Nrf2 activation.","date":"2017","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28939422","citation_count":27,"is_preprint":false},{"pmid":"19553535","id":"PMC_19553535","title":"Ncf1-associated reduced oxidative burst promotes IL-33R+ T cell-mediated adjuvant-free arthritis in mice.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19553535","citation_count":26,"is_preprint":false},{"pmid":"20178640","id":"PMC_20178640","title":"A copy number variation in human NCF1 and its pseudogenes.","date":"2010","source":"BMC genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20178640","citation_count":25,"is_preprint":false},{"pmid":"12618429","id":"PMC_12618429","title":"p47phox participates in activation of RelA in endothelial cells.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12618429","citation_count":25,"is_preprint":false},{"pmid":"10772875","id":"PMC_10772875","title":"Genomic structure of the human p47-phox (NCF1) gene.","date":"2000","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/10772875","citation_count":24,"is_preprint":false},{"pmid":"30651282","id":"PMC_30651282","title":"NCF1 (p47phox)-deficient chronic granulomatous disease: comprehensive genetic and flow cytometric analysis.","date":"2019","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/30651282","citation_count":23,"is_preprint":false},{"pmid":"32422541","id":"PMC_32422541","title":"p47phox deficiency impairs platelet function and protects mice against arterial and venous thrombosis.","date":"2020","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/32422541","citation_count":23,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":56553,"output_tokens":8721,"usd":0.150237,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18451,"output_tokens":5775,"usd":0.118315,"stage2_stop_reason":"end_turn"},"total_usd":0.268552,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"The PX domain of p47phox binds specifically to phosphatidylinositol-3,4-bisphosphate (PtdIns(3,4)P2); an Arg-to-Gln mutation in the PX domain found in chronic granulomatous disease patients eliminates this phosphoinositide binding.\",\n      \"method\": \"Lipid-binding assays, site-directed mutagenesis of PX domain\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro lipid binding assays combined with disease-linked mutagenesis; replicated conceptually across multiple phosphoinositide-binding studies\",\n      \"pmids\": [\"11433300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"During neutrophil activation, p47phox is phosphorylated on multiple C-terminal serine residues (Ser-303, Ser-304, Ser-320, Ser-328, Ser-345, Ser-348, and at least one of Ser-359/370/379); Ser-303, Ser-304, Ser-320, and Ser-328 are in PKC consensus sequences, while Ser-345 and Ser-348 are in MAPK (-PXSP-) consensus sequences.\",\n      \"method\": \"32Pi labeling of immunopurified p47phox from PMA-stimulated neutrophils, CNBr fragmentation, phosphopeptide mapping\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct phosphopeptide mapping in primary cells, replicated by multiple subsequent studies\",\n      \"pmids\": [\"8089108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Both p38 MAPK and ERK1/2 phosphorylate p47phox at the same proline-directed site(s) in vitro; JNK does not phosphorylate p47phox.\",\n      \"method\": \"In vitro kinase assays with purified p38, ERK, and JNK using recombinant p47phox as substrate\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro kinase assay with three kinases tested comparatively in a single study\",\n      \"pmids\": [\"8900416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Using 2D tryptic phosphopeptide mapping with p47phox Ser→Ala mutants expressed in B lymphoblasts: PKC phosphorylates peptides containing Ser303/304, Ser315, Ser320, Ser328, and Ser359/370; PKA phosphorylates Ser320 and Ser328/359/370; MAPK phosphorylates only Ser345/348. These three kinases thus phosphorylate distinct subsets of serines.\",\n      \"method\": \"Two-dimensional tryptic phosphopeptide mapping, site-directed mutagenesis (Ser→Ala), in vitro kinase assays with PKC, PKA, and MAPK\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution with multiple mutants and multiple purified kinases, confirmed in intact cells\",\n      \"pmids\": [\"8626435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GM-CSF and TNF-alpha prime NADPH oxidase activity by inducing phosphorylation of p47phox specifically at Ser345 via convergent MAPK pathways: ERK1/2 mediates GM-CSF-induced Ser345 phosphorylation, while p38 MAPK mediates TNF-alpha-induced Ser345 phosphorylation. A S345A mutant p47phox fails to support priming.\",\n      \"method\": \"Tandem mass spectrometry peptide sequencing, MAPK pathway inhibitors, S345A mutagenesis in HL-60 cells, cell-permeable TAT-peptide inhibition\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mass spectrometry identification + mutagenesis + inhibitor studies + peptide competition, multiple orthogonal methods\",\n      \"pmids\": [\"16778989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The ERK1/2 pathway participates in fMLP-induced p47phox phosphorylation in intact human neutrophils; ERK1/2 and PKC act additively on p47phox phosphorylation in fMLP-stimulated cells, identifying p47phox as a convergence point for these kinase cascades.\",\n      \"method\": \"ERK1/2 inhibitors (PD98059, U0126), PKC inhibitor (GF109203X), 2D phosphopeptide mapping in primary neutrophils\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — pharmacological inhibition with two orthogonal ERK inhibitors plus 2D phosphopeptide mapping in primary cells\",\n      \"pmids\": [\"11046057\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"PKC-zeta phosphorylates p47phox at Ser303/304 and Ser315 in vitro; PKC-zeta inhibition blocks fMLP-induced p47phox phosphorylation and membrane translocation as well as superoxide production in human neutrophils.\",\n      \"method\": \"In vitro kinase assay with recombinant PKC-zeta and p47phox, site-directed mutagenesis, cell-permeable peptide antagonist, antisense oligonucleotides in HL-60 cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay with mutagenesis plus antisense knockdown and peptide inhibition in primary cells\",\n      \"pmids\": [\"11145703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"p47phox directly interacts with PKC-beta(I), PKC-beta(II), and PKC-delta via its C-terminus; co-immunoprecipitation confirmed this interaction in intact cells; p47phox acts as a regulator of PKC localization and substrate phosphorylation in neutrophils.\",\n      \"method\": \"p47phox affinity chromatography to extract kinase, co-immunoprecipitation, subcellular fractionation in p47phox-deficient cells, in vitro reconstitution with rat brain cytosol\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — affinity chromatography identification plus reciprocal co-IP plus functional reconstitution in p47phox-null cells\",\n      \"pmids\": [\"10585874\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PKC-delta is required for p47phox phosphorylation and membrane translocation in activated human monocytes; p47phox serves as a direct substrate for PKC-delta in vitro.\",\n      \"method\": \"Pharmacological inhibitors (rottlerin), PKC-delta antisense oligonucleotides, in vitro kinase assay with recombinant p47phox-GST fusion protein\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay plus genetic (antisense) and pharmacological inhibition in primary human monocytes\",\n      \"pmids\": [\"15494525\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"PKC phosphorylation of p47phox induces a conformational change in the C-terminal region (detected by decreased reactivity of Cys378 to N-ethylmaleimide), revealing a binding site for interaction with cytochrome b558 during oxidase assembly.\",\n      \"method\": \"Chemical modification assay (N-ethylmaleimide reactivity) on PKC-phosphorylated vs. unphosphorylated p47phox, cell-free oxidase activation system\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct biochemical demonstration of phosphorylation-dependent conformational change with functional cell-free system validation\",\n      \"pmids\": [\"9200696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Kinase-dependent phosphorylation of p47phox is required for NADPH oxidase activation in a cell-free system; PKC-phosphorylated p47phox, but not PKA- or MAPK-phosphorylated p47phox, supports oxidase activation; the S379A mutant is inactive in both whole cells and in this cell-free system.\",\n      \"method\": \"Two-stage cell-free oxidase activation assay, kinase-phosphorylated p47phox preparations, S379A mutant analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cell-free reconstitution with site-specific mutants and defined phosphorylated substrates from three different kinases\",\n      \"pmids\": [\"9110996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Translocation of p47phox (and p67phox) from cytosol to plasma membrane is an essential and continuous requirement for NADPH oxidase activation; phosphorylation of p47phox can be dissociated from translocation (staurosporine markedly inhibits phosphorylation but not translocation).\",\n      \"method\": \"Subcellular fractionation, immunoblotting of p47phox and p67phox in normal and Ca2+-depleted neutrophils with multiple agonists, staurosporine inhibition\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — systematic dissection of phosphorylation vs. translocation using multiple agonists and inhibitors in primary cells\",\n      \"pmids\": [\"8439286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"The C-terminal proline-rich region of p47phox interacts with the second SH3 domain of p67phox; p47phox also interacts with p40phox; these interactions are not required for oxidase activity in the cell-free assay.\",\n      \"method\": \"Protein overlay (far Western), deletion mutagenesis of p47phox and p67phox, solution binding studies, cell-free oxidase assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct binding assay with defined deletion mutants plus functional cell-free assay\",\n      \"pmids\": [\"7744754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Crystal structure of the SH3 domain of p40phox (SH3p40) alone and in complex with a 12-residue proline-rich region of p47phox revealed that SH3p40 interacts with both a canonical polyproline motif and a non-canonical motif of the p47phox C-terminus. Phosphorylation of Ser-379 (but not Ser-359/370) destabilizes binding to both SH3p40 and C-SH3p67.\",\n      \"method\": \"X-ray crystallography (1.46 Å resolution), intrinsic tryptophan fluorescence binding measurements, phosphorylation-state analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus quantitative binding measurements with phosphopeptide variants\",\n      \"pmids\": [\"15657040\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The region of p47phox spanning residues 228-235 (specifically Thr233, and to a lesser degree Tyr231 and Val232) in the SH3 region is vital for NOX2 complex activation and for membrane translocation of p47phox upon stimulation.\",\n      \"method\": \"Site-directed mutagenesis of p47phox (deletion and single amino-acid substitutions), COS(PHOX) cell transfection, ROS assays, membrane translocation studies\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic mutagenesis of multiple residues with functional and localization readouts in a reconstituted cell system\",\n      \"pmids\": [\"23271700\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"p47phox associates with the actin-binding protein cortactin and co-localizes with F-actin in Ang II-stimulated human VSMCs; disruption of the actin cytoskeleton prevents p47phox:actin interaction and attenuates ROS generation and p38MAPK/Akt signaling.\",\n      \"method\": \"Co-immunoprecipitation (p47phox with actin and cortactin), immunofluorescence confocal microscopy, cytochalasin disruption with functional readouts\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP plus live-cell imaging plus functional inhibition, replicated across multiple experimental conditions\",\n      \"pmids\": [\"15618548\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"c-Src regulates Ang II-mediated NADPH oxidase activity by stimulating p47phox serine phosphorylation and translocation from cytosol to membrane; c-Src knockout cells show decreased p47phox phosphorylation and blunted Ang II-induced oxidase activation.\",\n      \"method\": \"Co-immunoprecipitation with anti-phosphoserine antibody, immunofluorescence, c-Src-/- mouse cells, c-Src inhibitor PP2\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout plus pharmacological inhibition in primary cells; single lab\",\n      \"pmids\": [\"12663375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"p47phox interacts with the tandem SH3 domains to bind the proline-rich region of p22phox, enabling NOX2 complex assembly; p47phox also activates Nox3 (in addition to gp91phox/NOX2), and deletion of the autoinhibitory region of p47phox renders it constitutively active toward both gp91phox and Nox3.\",\n      \"method\": \"Cell-based oxidase activation assays, autoinhibitory region deletion mutants, PMA stimulation experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-based functional assays with multiple mutants; single lab\",\n      \"pmids\": [\"15181005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Membrane-targeted PI3-kinase induces wortmannin-sensitive continuous phosphorylation of p47phox in monoblastic cells, placing PI3K upstream of p47phox phosphorylation.\",\n      \"method\": \"Transfection of membrane-targeted PI3K construct in GM-1 cells, wortmannin inhibition, immunoblotting for p47phox phosphorylation\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic gain-of-function plus pharmacological inhibition; single lab\",\n      \"pmids\": [\"8939574\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PI3K/p110alpha (but not p110beta) mediates PDGF-AA-dependent membrane recruitment of p47phox and Rac-1, leading to NOX activation and ROS production; p47phox-null cells fail to generate PDGF-dependent ROS; ROS are required for PDGF-dependent chemotaxis but not proliferation.\",\n      \"method\": \"p47phox-/- cells, dominant-negative Rac-1, mutant alphaPDGFR lacking specific signaling sites, PI3K isoform-specific inhibition, subcellular fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout plus multiple mutant receptors plus isoform-specific inhibition; multiple orthogonal approaches\",\n      \"pmids\": [\"18070887\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Cytosolic PCNA directly interacts with the PX domain of p47phox via its interdomain-connecting loop (demonstrated by surface plasmon resonance and crystallography), and this association regulates NADPH oxidase ROS production; PCNA inhibition decreases NADPH oxidase activation.\",\n      \"method\": \"Surface plasmon resonance, X-ray crystallography, competing peptides, PCNA inhibitor T2AA in vitro and in vivo (TNBS colitis model)\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus SPR binding plus functional inhibition in vitro and in vivo\",\n      \"pmids\": [\"31492810\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"p47phox directly interacts with RelA (NF-kappaB subunit) via its tandem SH3 domains binding to a proline-rich mid-region of RelA; this interaction facilitates IL-1beta-induced RelA phosphorylation and transactivation without affecting IkappaB degradation or RelA nuclear translocation.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, in vitro binding, co-localization by immunofluorescence, RelA-PR peptide competition, luciferase reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — yeast two-hybrid plus co-IP plus in vitro binding plus functional reporter assays with competing peptide; multiple orthogonal methods\",\n      \"pmids\": [\"12618429\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"p47phox physically binds to Nrf2 (but not p65phox or p40phox), suppresses Nrf2 ubiquitination by Keap1 (while p47phox itself becomes ubiquitinated by Keap1), and promotes Nrf2 nuclear translocation and target gene expression.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays, p47phox genetic ablation, selective p47phox overexpression in mouse lungs\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus ubiquitination assay plus KO phenotype; single lab\",\n      \"pmids\": [\"28939422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Ncf1/p47phox expression in Tregs is required for NADPH oxidase-derived ROS-mediated direct suppression of CD4+ effector T cells; Ncf1-deficient Tregs suppress Ncf1-deficient Teffs very poorly; NADPH oxidase inhibitors and antioxidants block WT Treg-mediated suppression.\",\n      \"method\": \"Treg/Teff co-culture suppression assays with Ncf1-/- mice, NADPH oxidase inhibitors (DPI, VAS-2870), antioxidants (NAC, 2-ME), flow cytometry of CFSE dilution\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout plus pharmacological inhibition in cell-based assays; single lab\",\n      \"pmids\": [\"21253614\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Fusion proteins linking truncated p47phox(1-286) N-terminally to truncated p67phox(1-210) reconstitute NADPH oxidase with 8-fold higher efficiency and greater stability than individual components, and show nearly full activation without anionic amphiphile, supporting a model of direct p47phox-p67phox-cytochrome b558 topology.\",\n      \"method\": \"Cell-free NADPH oxidase reconstitution with fusion protein constructs, superoxide production assays, Km determination for NADPH\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cell-free reconstitution with systematically designed fusion proteins; single lab\",\n      \"pmids\": [\"11333262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"HBP1 transcriptional repressor directly binds six tandem HBP1 DNA-binding elements at positions -1243 to -1318 bp of the p47phox gene promoter, represses p47phox endogenous gene expression in a sequence-specific manner, and thereby reduces intracellular superoxide production to inhibit G1 cell cycle progression.\",\n      \"method\": \"Promoter-reporter assays, HBP1 dominant-negative mutant, electrophoretic mobility shift, chromatin immunoprecipitation (implied), intracellular superoxide measurement\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter binding demonstrated plus functional consequences of HBP1 expression/dominant-negative; single lab\",\n      \"pmids\": [\"15024088\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SRF recruits the histone acetyltransferase KAT8 to epigenetically activate NCF1/NCF2 transcription during hepatic stellate cell activation, thereby increasing ROS production and promoting liver fibrosis; SRF conditional knockout reduces NCF1/NCF2 expression and ROS in HSCs.\",\n      \"method\": \"HSC-conditional SRF knockout mice, chromatin immunoprecipitation, co-immunoprecipitation of SRF with KAT8, siRNA knockdown, ROS measurement\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO mouse plus ChIP plus co-IP showing SRF-KAT8 interaction at NCF1 promoter; single lab\",\n      \"pmids\": [\"31442911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Aryl hydrocarbon receptor (AhR) directly binds a xenobiotic-responsive element (XRE) in the NCF1 promoter upon benzo(a)pyrene stimulation, inducing NCF1/p47phox transcription, protein translocation, and priming of macrophage superoxide production.\",\n      \"method\": \"AhR siRNA knockdown, chemical AhR inhibition, NCF1 promoter-luciferase assay, EMSA, chromatin immunoprecipitation, p47phox translocation and ROS assays\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus EMSA plus promoter-reporter assay plus functional ROS measurements; single lab\",\n      \"pmids\": [\"19559082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"p47phox is genetically required for superoxide production by microglial cells: p47phox-deficient microglia fail to produce superoxide, and retroviral transduction of human p47phox cDNA restores superoxide generation with normal kinetics.\",\n      \"method\": \"p47phox-/- knockout mice, primary microglial cultures, retroviral transduction with human p47phox cDNA, superoxide assays\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO plus rescue by cDNA complementation in primary cells\",\n      \"pmids\": [\"11156938\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The PX domain of p47phox translocates to the plasma membrane in activated human neutrophils but does not associate with the membrane of mature phagosomes (unlike RhoB).\",\n      \"method\": \"Nucleofection of primary human neutrophils with GFP-tagged p47phox PX domain constructs, live-cell fluorescence microscopy\",\n      \"journal\": \"BMC immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct live imaging in primary human cells with specific domain construct; single lab\",\n      \"pmids\": [\"17150107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"A single nucleotide polymorphism at position 153 of Ncf1 (M153T substitution, located in the hinge region between PX and SH3 domains) regulates ROS production and arthritis resistance; it does not affect p47phox/p67phox cytosolic complex assembly or membrane localization but likely affects downstream NOX2 complex activity at the membrane.\",\n      \"method\": \"COS(PHOX) cell transfection with mutated Ncf1 constructs, backcross genetics to DA strain, granulocyte ROS assays, p47phox/p67phox co-assembly and membrane localization assays\",\n      \"journal\": \"Antioxidants & redox signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional mutagenesis in cell system plus backcross genetics; single lab\",\n      \"pmids\": [\"21275845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NCF1 p.R90H variant reduces p47phox affinity for phospholipids, impairing its endosomal localization; the resulting defect in NOX2-derived ROS at endosomes leads to acidified endosomal pH and facilitated TLR-dependent signaling in plasmacytoid dendritic cells, promoting lupus pathogenesis.\",\n      \"method\": \"Human NCF1 p.R90H knockin mice, pDC-conditional Cre knockout, phospholipid binding assays, endosomal pH measurement, TLR signaling assays, IFN-α measurement\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockin mice plus phospholipid binding assays plus mechanistic pathway analysis; single lab\",\n      \"pmids\": [\"35788118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NCF1-dependent ROS production in plasmacytoid dendritic cells (pDCs) suppresses lupus by limiting pDC accumulation through inhibition of the AKT/mTOR pathway and CCR2-mediated tissue migration, and by dampening the STING/IFN-α/JAK1/STAT1 cascade.\",\n      \"method\": \"Cell-specific Cre-deleter knockout mice, NCF1-339 human variant knockin mice, transgenic reconstitution, AKT/mTOR pathway analysis, IFN-α and STING pathway measurements\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific genetic ablation with multiple mechanistic pathway readouts; single lab\",\n      \"pmids\": [\"36853827\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Macrophage NCF1 promotes Kupffer cell ferroptosis and MASH progression by oxidizing phospholipids; the oxidized phospholipids trigger TLR4-dependent hepcidin production in hepatocytes, leading to increased iron deposition and subsequent ferroptosis in Kupffer cells.\",\n      \"method\": \"Macrophage-specific NCF1 knockout mice, oxidized phospholipid measurements, TLR4 signaling assays, hepcidin measurement, iron deposition and ferroptosis assays\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific KO with mechanistic pathway dissection; single lab, multiple readouts\",\n      \"pmids\": [\"38851189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"p47phox translocates to the membrane in platelets after CRP or thrombin stimulation and interacts with both NOX1 and NOX2; p47phox deficiency impairs platelet ROS generation, aggregation, spreading, and clot retraction, and reduces phosphorylation of Syk and PLCγ2.\",\n      \"method\": \"p47phox-/- mice, platelet function assays, co-immunoprecipitation of p47phox with NOX1 and NOX2, phosphorylation analysis, in vivo thrombosis models\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO plus co-IP in stimulated platelets plus multiple functional assays; single lab\",\n      \"pmids\": [\"32422541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Fragment-based drug discovery using fluorescence polarization and surface plasmon resonance identified small molecules binding to two distinct sites in the tandem SH3 domain of p47phox (p47phoxSH3A-B); a dimeric optimized compound inhibits the p47phoxSH3A-B–p22phox protein-protein interaction with Ki of 20 μM.\",\n      \"method\": \"Fragment screening by FP and thermal shift assay, SPR validation, structural studies, p22phox competition assay\",\n      \"journal\": \"Journal of medicinal chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — SPR binding plus structural characterization plus competition assay defining interaction sites; single lab\",\n      \"pmids\": [\"31922756\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PKCδ co-immunoprecipitates with p47phox in methamphetamine-treated mouse brain; PKCδ knockout or p47phox knockout each abolish methamphetamine-induced increases in NADPH oxidase activity and ROS, and rottlerin (PKCδ inhibitor) provides no additive protection over p47phox knockout, placing PKCδ upstream of p47phox in this pathway.\",\n      \"method\": \"Co-immunoprecipitation, PKCδ and p47phox knockout mice, PKCδ antisense oligonucleotides, NADPH oxidase activity and ROS assays\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus genetic double-KO epistasis; single lab\",\n      \"pmids\": [\"29269308\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NCF1/p47phox is a cytosolic organizer subunit of the phagocyte NADPH oxidase (NOX2 complex) that, upon cell activation, undergoes PKC-, ERK1/2-, p38 MAPK-, and PKCδ/ζ-mediated multi-site serine phosphorylation (key sites: Ser303/304, Ser315, Ser320, Ser328, Ser345, Ser348, Ser379) triggering a conformational change that relieves autoinhibition and enables p47phox to translocate from cytosol to the plasma membrane via its PX domain (which binds PtdIns(3,4)P2) and its tandem SH3 domains (which bind the proline-rich region of p22phox), assembling the active oxidase complex with p67phox, p40phox, Rac, and flavocytochrome b558 to generate superoxide; p47phox also scaffolds PKC isoforms, interacts with the actin cytoskeleton through cortactin, directly binds RelA to facilitate NF-κB transactivation, and interacts with PCNA and Nrf2 to modulate oxidative stress responses, while functioning in NOX1 and Nox3 regulation as well.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NCF1/p47phox is the cytosolic organizer subunit of the phagocyte NADPH oxidase, providing the regulated assembly step that gates superoxide generation by the membrane flavocytochrome b558/NOX complex [#11, #28]. In resting cells p47phox is autoinhibited; cell activation triggers PKC-, ERK1/2-, and p38 MAPK-mediated phosphorylation of a cluster of C-terminal serines, with distinct kinases targeting distinct sites \\u2014 PKC isoforms (including PKC\\u03b6 at Ser303/304/315 and PKC\\u03b4) act on the PKC consensus serines while MAPKs act exclusively on the proline-directed Ser345/Ser348 [#1, #3, #6, #8]. This phosphorylation induces a conformational change in the C-terminus that exposes binding surfaces required for assembly [#9], and only PKC-phosphorylated p47phox supports oxidase activation in cell-free reconstitution, with Ser379 essential for activity [#10]. Once de-repressed, p47phox docks at the membrane through its PX domain, which binds PtdIns(3,4)P2 [#0], and its tandem SH3 domains, which engage the proline-rich region of p22phox, nucleating complex assembly with p67phox and p40phox [#12, #13, #17]. Phosphorylation at sites such as Ser345 underlies cytokine priming (GM-CSF via ERK1/2, TNF-\\u03b1 via p38) of the oxidase [#4], and upstream PI3K signaling and c-Src feed into p47phox phosphorylation and recruitment in non-phagocytic cells [#16, #18, #19]. Beyond the canonical oxidase, p47phox scaffolds PKC isoforms via its C-terminus [#7], associates with the actin cytoskeleton through cortactin [#15], directly binds RelA through its SH3 domains to facilitate NF-\\u03baB transactivation [#21], and binds PCNA and Nrf2 to tune oxidative-stress responses [#20, #22]. Disease-relevant variants illustrate its physiology: a PX-domain Arg-to-Gln mutation abolishing phosphoinositide binding underlies chronic granulomatous disease [#0], and the R90H variant impairing endosomal phospholipid binding promotes TLR-driven lupus pathogenesis [#31]. p47phox-dependent ROS additionally regulate immune and tissue homeostasis, from Treg-mediated suppression of effector T cells [#23] to platelet activation [#34] and roles in fibrosis and MASH progression [#26, #33].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Established that p47phox membrane translocation, not merely its phosphorylation, is the obligate continuous step for oxidase activation, separating two regulatory events that had been conflated.\",\n      \"evidence\": \"Subcellular fractionation and immunoblotting in normal and Ca2+-depleted neutrophils with staurosporine\",\n      \"pmids\": [\"8439286\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the membrane docking determinants\", \"Mechanism coupling phosphorylation to translocation unresolved\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Mapped the C-terminal multi-site serine phosphorylation of activated p47phox and assigned sites to PKC versus MAPK consensus motifs, defining the substrate landscape for oxidase regulation.\",\n      \"evidence\": \"32Pi labeling, CNBr fragmentation, and phosphopeptide mapping of p47phox from PMA-stimulated neutrophils\",\n      \"pmids\": [\"8089108\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which kinases hit which sites in vivo not established\", \"Functional consequence of individual sites untested here\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Resolved that PKC, PKA, and MAPK phosphorylate distinct serine subsets, with MAPK restricted to the proline-directed Ser345/348, establishing p47phox as an integration node for multiple kinase cascades.\",\n      \"evidence\": \"2D tryptic phosphopeptide mapping of Ser\\u2192Ala mutants in B lymphoblasts and in vitro kinase assays; comparative in vitro assays with p38, ERK, JNK\",\n      \"pmids\": [\"8626435\", \"8900416\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not test which sites drive activation versus priming\", \"In-cell stoichiometry not quantified\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrated that phosphorylation acts mechanistically by inducing a C-terminal conformational change and that only PKC-phosphorylated p47phox (with Ser379 intact) supports activation, providing the causal link between phosphorylation and assembly.\",\n      \"evidence\": \"N-ethylmaleimide reactivity assay and two-stage cell-free oxidase reconstitution with kinase-specific phosphorylated p47phox and S379A mutant\",\n      \"pmids\": [\"9200696\", \"9110996\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic structure of the conformational change not resolved\", \"Why PKA/MAPK phosphorylation is insufficient alone unexplained\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Identified the SH3-mediated and proline-rich interactions linking p47phox to p67phox and p40phox, beginning the structural map of complex assembly.\",\n      \"evidence\": \"Far-Western overlay, deletion mutagenesis, and solution binding with cell-free oxidase assay\",\n      \"pmids\": [\"7744754\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"These interactions found dispensable in cell-free assay, leaving their in-cell role open\", \"Did not define p22phox docking\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Defined the PX domain as a PtdIns(3,4)P2-binding membrane-targeting module and tied a CGD patient mutation to loss of this binding, explaining how p47phox is recruited to membranes.\",\n      \"evidence\": \"Lipid-binding assays with PX-domain site-directed and disease-linked mutagenesis\",\n      \"pmids\": [\"11433300\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address SH3-mediated p22phox docking\", \"In vivo lipid specificity in different cell types not tested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Placed PKC\\u03b6 and membrane-targeted PI3K upstream of p47phox phosphorylation and translocation, extending the activating kinase network beyond conventional PKC.\",\n      \"evidence\": \"In vitro kinase assays with recombinant PKC\\u03b6, antisense/peptide inhibition in HL-60 cells; membrane-targeted PI3K transfection with wortmannin\",\n      \"pmids\": [\"11145703\", \"8939574\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"PKC\\u03b6 vs conventional PKC site selectivity in vivo unresolved\", \"PI3K-to-kinase connection indirect\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showed p47phox also activates Nox3 and binds the p22phox proline-rich region via tandem SH3 domains, and that PKC\\u03b4 drives its phosphorylation/translocation in monocytes, broadening its NOX-organizing role.\",\n      \"evidence\": \"Cell-based oxidase assays with autoinhibitory deletion mutants; PKC\\u03b4 antisense, rottlerin, and in vitro kinase assays in monocytes\",\n      \"pmids\": [\"15181005\", \"15494525\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"NOX-isoform selectivity determinants not mapped\", \"Single-lab cell-based data\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Provided atomic detail of p40phox SH3 binding to canonical and non-canonical motifs of the p47phox C-terminus and showed Ser379 phosphorylation destabilizes these interactions, linking phosphorylation to release of intramolecular/intermolecular contacts.\",\n      \"evidence\": \"1.46 \\u00c5 crystal structure of SH3p40\\u2013p47phox peptide complex with tryptophan-fluorescence binding measurements\",\n      \"pmids\": [\"15657040\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length autoinhibited structure not solved\", \"Dynamics of the phosphorylation switch not captured\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Established Ser345 as the molecular basis of cytokine priming, with GM-CSF/ERK1/2 and TNF-\\u03b1/p38 converging on this single residue, explaining how inflammatory signals amplify oxidase output.\",\n      \"evidence\": \"Tandem MS, MAPK inhibitors, S345A mutagenesis in HL-60, and TAT-peptide inhibition\",\n      \"pmids\": [\"16778989\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Ser345 phosphorylation primes without full activation not detailed\", \"Proline isomerase involvement not addressed\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstrated genetic requirement for p47phox in oxidase function via knockout and cDNA rescue, formally establishing it as essential and non-redundant for superoxide production.\",\n      \"evidence\": \"p47phox-/- microglia with retroviral human p47phox cDNA complementation and superoxide assays\",\n      \"pmids\": [\"11156938\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address tissue-specific roles\", \"ERK pathway contribution to fMLP response left to other work\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Revealed moonlighting roles of p47phox beyond superoxide production: scaffolding cortactin/actin and directly binding RelA to facilitate NF-\\u03baB transactivation, connecting the oxidase organizer to cytoskeleton and transcription.\",\n      \"evidence\": \"Reciprocal co-IP and imaging in VSMCs; yeast two-hybrid, co-IP, in vitro binding, and reporter assays for RelA; c-Src KO/inhibitor studies\",\n      \"pmids\": [\"15618548\", \"12618429\", \"12663375\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether scaffolding functions require oxidase activity unclear\", \"RelA interaction effects on specific target genes incompletely mapped\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified an SH3-region segment (Thr233/Tyr231/Val232) and an M153T hinge polymorphism as determinants of membrane translocation and ROS output, refining the structural map of activation control.\",\n      \"evidence\": \"Systematic mutagenesis in COS(PHOX) cells with ROS and translocation readouts; backcross genetics linking M153T to arthritis resistance\",\n      \"pmids\": [\"23271700\", \"21275845\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which M153T alters membrane-stage activity unresolved\", \"Single reconstituted cell system\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Extended p47phox into redox-homeostasis and stress signaling by showing it binds Nrf2 to block Keap1-mediated ubiquitination and scaffolds PKC\\u03b4 in neurotoxicity, positioning it as a regulator of antioxidant transcription and PKC localization.\",\n      \"evidence\": \"Co-IP, ubiquitination assays, and p47phox genetic ablation for Nrf2; co-IP and PKC\\u03b4/p47phox double-KO epistasis in methamphetamine-treated brain\",\n      \"pmids\": [\"28939422\", \"29269308\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct Nrf2 binding interface not defined\", \"Single-lab studies\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Discovered direct PCNA binding to the p47phox PX domain and transcriptional control of NCF1 by SRF/KAT8, adding cytosolic-cofactor and epigenetic layers to oxidase regulation.\",\n      \"evidence\": \"SPR and crystallography with PCNA inhibitor in colitis model; conditional SRF-KO mice with ChIP and SRF-KAT8 co-IP\",\n      \"pmids\": [\"31492810\", \"31442911\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How PCNA binding integrates with phosphorylation switch unclear\", \"SRF/KAT8 mechanism shown in single tissue context\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Linked NCF1 sequence variants to autoimmune and metabolic disease mechanisms: R90H impairs endosomal phospholipid binding to promote TLR-driven lupus, while NCF1-derived ROS otherwise restrain pDC accumulation and IFN-\\u03b1 signaling.\",\n      \"evidence\": \"Human variant knockin and pDC-conditional KO mice with phospholipid binding, endosomal pH, and TLR/STING/IFN-\\u03b1 readouts\",\n      \"pmids\": [\"35788118\", \"36853827\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cell-type-specific contributions of endosomal vs plasma-membrane ROS not fully separated\", \"Single-lab disease models\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined a pathogenic axis in which macrophage NCF1 oxidizes phospholipids to drive TLR4/hepcidin-dependent iron-mediated Kupffer cell ferroptosis in MASH, illustrating tissue-level consequences of NCF1-dependent ROS.\",\n      \"evidence\": \"Macrophage-specific NCF1-KO mice with oxidized phospholipid, TLR4, hepcidin, and ferroptosis assays; platelet p47phox-/- studies of NOX1/NOX2 interaction\",\n      \"pmids\": [\"38851189\", \"32422541\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether oxidized-phospholipid signaling is direct or via secondary mediators unclear\", \"Single-lab models\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the multi-site phosphorylation code, PX/SH3 lipid and protein docking, and cytosolic cofactors (PCNA, PKC isoforms) are integrated into a unified quantitative activation switch in full-length p47phox remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No full-length structure of the autoinhibited or assembled complex\", \"Site-by-site contribution to activation vs priming not quantitatively reconciled\", \"NOX-isoform-selective regulation determinants undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [12, 13, 17, 21]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [0, 29, 31]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [7, 17, 22]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [11, 7]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [11, 0, 29]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [31]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [15]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [28, 23, 31, 32]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [4, 22, 20]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [21, 16, 19]}\n    ],\n    \"complexes\": [\"NADPH oxidase (NOX2) complex\"],\n    \"partners\": [\"CYBA\", \"NCF2\", \"NCF4\", \"RELA\", \"PCNA\", \"NFE2L2\", \"CTTN\", \"PRKCD\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}